Thank you.
I also want to go back to the MS monitoring system, which Ms. Elmslie spoke about, that was announced in March 2011.
I know my colleague asked whether or not we will be tracking all Canadians who have received the CCSVI treatment. I want to know if you can expand on why it is important to do this—first of all, to have the monitoring system, and second, why it may be important to ensure that we capture those individuals who have received the CCSVI.